FIELD: medicine.
SUBSTANCE: aqueous solution is applied that includes compound 22 having the structural formula 
or its pharmaceutically acceptable salt, which is administered to the patient in the form of intravenous infusion, intravenous bolus or subcutaneously, or a pharmaceutical composition containing an effective amount of compound 22, while the specified composition is either dried or is an aqueous solution.
EFFECT: increased efficiency of fungal infection treatment with reduced dosage and frequency of drug administration due to the improved pharmacokinetic profile of the compound.
15 cl, 22 dwg, 14 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS | 2013 |
|
RU2719579C2 |
| PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TAXANES AND METHODS FOR TREATMENT USING THEREOF | 1999 |
|
RU2236226C2 |
| COMBINED THERAPY FOR IMMUNE DISEASE TREATMENT | 2004 |
|
RU2329037C2 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
| COMPOSITIONS AND METHODS FOR APOLIPOPROTEIN C-III (APOC3) GENE EXPRESSION INHIBITION | 2012 |
|
RU2631805C2 |
| FORMULATIONS FOR ORAL ADMINISTRATION OF DRUG PREPARATIONS AND RELATED METHODS | 2008 |
|
RU2485975C2 |
| ORAL ADMINISTRATION OF UNSTABLE OR POORLY ABSORBED DRUGS | 2015 |
|
RU2746548C2 |
| ANTIFUNGAL AGENTS | 2015 |
|
RU2727520C2 |
